Intelligence Driven Advisers LLC Acquires 276 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Intelligence Driven Advisers LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,042 shares of the healthcare conglomerate’s stock after buying an additional 276 shares during the quarter. Intelligence Driven Advisers LLC’s holdings in UnitedHealth Group were worth $533,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Robbins Farley bought a new position in UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC grew its stake in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock traded up $8.06 during midday trading on Thursday, reaching $492.17. 1,694,489 shares of the stock were exchanged, compared to its average volume of 4,411,779. The stock has a market capitalization of $452.84 billion, a PE ratio of 29.98, a P/E/G ratio of 1.40 and a beta of 0.55. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a fifty day moving average price of $483.69 and a 200 day moving average price of $513.21.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.26 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on UNH. TD Cowen cut their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Barclays lifted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.